ARS Pharmaceuticals, Inc. (SPRY)
Market Cap | 1.06B |
Revenue (ttm) | 10,000 |
Net Income (ttm) | -49.70M |
Shares Out | 96.90M |
EPS (ttm) | -0.52 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 578,592 |
Open | 11.25 |
Previous Close | 11.19 |
Day's Range | 10.93 - 11.35 |
52-Week Range | 2.55 - 11.90 |
Beta | n/a |
Analysts | Buy |
Price Target | 18.33 (+66.94%) |
Earnings Date | Aug 8, 2024 |
About SPRY
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for the emergency treatment of Type I allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California. [Read more]
Financial Performance
In 2023, SPRY's revenue was $30,000, a decrease of -97.72% compared to the previous year's $1.32 million. Losses were -$54.37 million, 56.8% more than in 2022.
Financial StatementsAnalyst Forecast
According to 4 analysts, the average rating for SPRY stock is "Buy." The 12-month stock price forecast is $18.33, which is an increase of 66.94% from the latest price.
News
![](https://cdn.snapi.dev/images/v1/e/3/press9-2549435.jpg)
ARS Pharmaceuticals Inc Investigated By The Schall Law Firm And Impacted Investors Urged To Engage In Dialogue
LOS ANGELES, CA / ACCESSWIRE / July 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica...
![](https://cdn.snapi.dev/images/v1/e/z/press10-2546529.jpg)
ARS Pharmaceuticals Inc Investigated By The Schall Law Firm And Impacted Investors Urged To Engage In Dialogue
LOS ANGELES, CA / ACCESSWIRE / July 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica...
![](https://cdn.snapi.dev/images/v1/i/e/press3-2543742.jpg)
ARS Pharmaceuticals Inc Investigated By The Schall Law Firm And Impacted Investors Urged To Engage In Dialogue
LOS ANGELES, CA / ACCESSWIRE / July 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica...
![](https://cdn.snapi.dev/images/v1/h/e/press3-2537681.jpg)
ARS Pharmaceuticals Inc Is Under Investigation By The Schall Law Firm And Impacted Investors Are Encouraged To Initiate Dialogue
LOS ANGELES, CA / ACCESSWIRE / July 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica...
![](https://cdn.snapi.dev/images/v1/z/4/press6-2535004.jpg)
ARS Pharmaceuticals Inc Is Under Investigation By The Schall Law Firm And Impacted Investors Are Encouraged To Initiate Dialogues
LOS ANGELES, CA / ACCESSWIRE / July 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica...
![](https://cdn.snapi.dev/images/v1/d/l/press2-2532968.jpg)
The Schall Law Firm Is Investigating ARS Pharmaceuticals Inc And Urges Affected Investors To Start Conversations
LOS ANGELES, CA / ACCESSWIRE / July 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica...
![](https://cdn.snapi.dev/images/v1/x/m/press14-2529973.jpg)
ARS Pharmaceuticals Inc Is Under Examination By The Schall Law Firm, Impacted Investors Are Encouraged To Initiate Dialogues
LOS ANGELES, CA / ACCESSWIRE / July 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica...
![](https://cdn.snapi.dev/images/v1/4/p/press2-2527700.jpg)
The Schall Law Firm Urges Affected Investors To Start Conversation, ARS Pharmaceuticals Inc Is Under Scrutiny
LOS ANGELES, CA / ACCESSWIRE / July 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica...
![](https://cdn.snapi.dev/images/v1/g/r/press1-2525376.jpg)
ARS Pharmaceuticals Inc Under Investigation By The Schall Law Firm Encouraging Impacted Investors To Initiate Dialogue
LOS ANGELES, CA / ACCESSWIRE / July 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica...
![](https://cdn.snapi.dev/images/v1/x/v/press12-2523316.jpg)
The Schall Law Firm Begins Probe Into ARS Pharmaceuticals Inc And Urges Affected Investors To Start Conversation
LOS ANGELES, CA / ACCESSWIRE / July 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica...
![](https://cdn.snapi.dev/images/v1/n/5/press12-2522862.jpg)
Investigation Into ARS Pharmaceuticals Inc Initiated By The Schall Law Firm Encouraging Impacted Investors To Begin Dialogue
LOS ANGELES, CA / ACCESSWIRE / July 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica...
![](https://cdn.snapi.dev/images/v1/n/d/press4-2520517.jpg)
ARS Pharmaceuticals Inc Under Investigation By The Schall Law Firm Urging Affected Investors To Initiate Conversation
LOS ANGELES, CA / ACCESSWIRE / July 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica...
![](https://cdn.snapi.dev/images/v1/j/n/press17-2518207.jpg)
The Schall Law Firm Initiates Inquiry Into ARS Pharmaceuticals Inc And Encourages Impacted Investors To Start Dialogue
LOS ANGELES, CA / ACCESSWIRE / July 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica...
![](https://cdn.snapi.dev/images/v1/j/g/press4-2515897.jpg)
The Schall Law Firm Starts Investigation Into ARS Pharmaceuticals Inc And Urges Affected Investors To Begin Interaction
LOS ANGELES, CA / ACCESSWIRE / July 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical...
![](https://cdn.snapi.dev/images/v1/s/u/press13-2513539.jpg)
The Schall Law Firm Initiates Probe Into ARS Pharmaceuticals Inc And Encourages Impacted Investors To Start Interaction
LOS ANGELES, CA / ACCESSWIRE / July 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical...
![](https://cdn.snapi.dev/images/v1/j/6/press15-2511902.jpg)
The Schall Law Firm Starts Scrutiny Of Allegations Against ARS Pharmaceuticals Inc And Promotes Investors With Losses To Take Part
LOS ANGELES, CA / ACCESSWIRE / July 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical...
![](https://cdn.snapi.dev/images/v1/r/t/press18-2511599.jpg)
Investigation Into ARS Pharmaceuticals Inc Is Launched By The Schall Law Firm And It Motivates Affected Investors To Engage
LOS ANGELES, CA / ACCESSWIRE / July 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical...
![](https://cdn.snapi.dev/images/v1/k/q/press13-2511245.jpg)
The Schall Law Firm Initiates Examination Into Accusations Against ARS Pharmaceuticals Inc And Encourages Impacted Investors To Participate
LOS ANGELES, CA / ACCESSWIRE / July 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical...
![](https://cdn.snapi.dev/images/v1/d/j/press15-2508928.jpg)
The Schall Law Firm Commences Inquiry Into Allegations Against ARS Pharmaceuticals Inc And Urges Affected Investors To Get Involved
LOS ANGELES, CA / ACCESSWIRE / July 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical...
![](https://cdn.snapi.dev/images/v1/p/i/press3-2507333.jpg)
Probe Into Claims Against ARS Pharmaceuticals Inc Initiated By The Schall Law Firm And Impacted Investors Are Encouraged To Participate
LOS ANGELES, CA / ACCESSWIRE / July 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical...
![](https://cdn.snapi.dev/images/v1/i/r/press7-2502237.jpg)
The Schall Law Firm Initiates Probe Into Claims Against ARS Pharmaceuticals Inc And Urges Affected Investors To Participate
LOS ANGELES, CA / ACCESSWIRE / June 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica...
![](https://cdn.snapi.dev/images/v1/v/y/press17-2501467.jpg)
ARS Pharmaceuticals Announces EURneffy (adrenaline nasal spray) Recommended for Approval by CHMP for Emergency Treatment of Allergic Reactions (anaphylaxis)
EURneffy positioned to be the first and only needle-free adrenaline option authorized for emergency treatment of allergic reactions (anaphylaxis) in Europe
![](https://cdn.snapi.dev/images/v1/p/k/press1-2498974.jpg)
The Schall Law Firm Begins Investigation Into Allegations Against ARS Pharmaceuticals Inc And Encourages Impacted Investors To Get Involved
LOS ANGELES, CA / ACCESSWIRE / June 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica...
![](https://cdn.snapi.dev/images/v1/q/b/press13-2496080.jpg)
The Schall Law Firm Begins Investigation Into Allegations Against ARS Pharmaceuticals Inc And Encourages Impacted Investors To Join
LOS ANGELES, CA / ACCESSWIRE / June 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica...
![](https://cdn.snapi.dev/images/v1/i/j/press2-2491888.jpg)
The Schall Law Firm Starts Investigation Into Allegations Against ARS Pharmaceuticals Inc And Encourages Impacted Investors To Get Involved
LOS ANGELES, CA / ACCESSWIRE / June 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica...